| Overview |
| bs-9562R-FITC |
| LAPTM4A Polyclonal Antibody, FITC Conjugated |
| WB |
| Human, Mouse, Rat |
| Specifications |
| FITC |
| Rabbit |
| KLH conjugated synthetic peptide derived from human LAPTM4A |
| 101-200/233 |
| Polyclonal |
| IgG |
| 1ug/ul |
| Purified by Protein A. |
| Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol. |
| Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. |
| Target |
| 9741 |
| Q15012 |
| Endoplasmic reticulum |
| Golgi 4 transmembrane spanning transporter MTP; Golgi 4-transmembrane-spanning transporter MTP; HUMORF13; KIAA0108; LAP4A_HUMAN; LAPTM4; LAPTM4A; Lysosomal associated protein transmembrane 4 alpha; Lysosomal associated transmembrane protein 4A; Lysosomal protein transmembrane 4 alpha; Lysosomal-associated transmembrane protein 4A; MBNT; Membrane nucleoside transporter; MTRP. |
| Lysosomal-associated transmembrane protein 4A (LAPTM4A), also known as Golgi 4-transmembrane spanning transporter MTP, is a 233 amino acid protein belonging to the LAPTM5/LAPTM5 transporter family. LAPTM4A is subcellularly localized to the intracytoplasmic membrane and has the potential to reside in intracellular membrane-bound compartments. LAPTM4A is thought to function as a transporter of nucleosides and/or nucleoside derivatives between the cytosol and the lumen of intracellular compartments. LAPTM4A is predicted to have four transmembrane domains, with the C-terminal domain being required for retention of the protein within intracellular membranes.
May function in the transport of nucleosides and/or nucleoside derivatives between the cytosol and the lumen of an intracellular membrane-bound compartment |
| Application Dilution |
| WB |
1:300-5000 |
Powered by Bioz